SCHEMBL6947517

SCHEMBL6947517

Cc1nc(Cl)c([N+](=O)[O-])c(N2CCc3ccccc3CC2)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
HTT P42858 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
MAPT P10636 5/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
GPR55 Q9Y2T6 1/20 0.42
POLB P06746 2/20 0.42
HTR1A P08908 2/20 0.41
HTR2A P28223 1/20 0.41
HTR7 P34969 1/20 0.41
HTR6 P50406 1/20 0.41
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
ALDH1A1 P00352 1/20 0.40
NPY5R Q15761 1/20 0.40
EED O75530 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6949469 0.87 POLB (0.43) MEN1KMT2AHTTSMN1; SMN2MAPT
SCHEMBL6951809 0.85 MEN1 (0.40) MEN1KMT2AHTTSMN1; SMN2MAPT
SCHEMBL9122461 0.85 MAPT (0.47) KMT2AHTTMAPTCYP1A2CYP3A4
SCHEMBL5773495 0.83 HTT (0.52) MEN1KMT2AHTTMAPTCYP1A2
SCHEMBL6957503 0.82 MGMT (0.44) MEN1KMT2AHTTSMN1; SMN2MAPT
SCHEMBL6948779 0.81 HTT (0.52) MEN1KMT2AHTTSMN1; SMN2MAPT
SCHEMBL9126475 0.81 ALDH1A1 (0.56) MEN1KMT2AHTTSMN1; SMN2MAPT
SCHEMBL6951003 0.79 MGMT (0.42) MEN1KMT2AHTTSMN1; SMN2MAPT
SCHEMBL6945292 0.79 MGMT (0.45) MEN1KMT2AHTTSMN1; SMN2MAPT
SCHEMBL6953559 0.79 MAPT (0.49) MEN1KMT2AHTTSMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074549-B1 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors HOFFMANN LA ROCHE (CH) 2003-11-19 EP disclosed
US-6218385-B1 FOR THERAPY OR PROPHYLAXIS OF ACUTE AND/OR CHRONIC NEUROLOGICAL DISORDERS SUCH AS EPILEPSY, STROKE, CHRONIC AND ACUTE PAIN, PSYCHOSIS, SCHIZOPHRENIA, ALZHEIMER'S DISEASE, COGNITIVE DISORDERS AND MEMORY DEFICITS HOFFMANN-LA ROCHE INC. 2001-04-17 US disclosed
EP-1074549-A2 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors F. HOFFMANN-LA ROCHE AG (CH) 2001-02-07 EP disclosed